Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Dead

Total Raised


Last Raised


About Jomaa Pharmaka

Developer of drugs to treat malaria and multiple sclerosis. The company has discovered the inherent factor missing in the human immune system which makes human beings susceptible to diseases such as malaria, multiple sclerosis and tuberculosis, and is developing drugs based on this factor, both to combat these ailments, and for use in applications in herbicides.

Jomaa Pharmaka Headquarters Location

Frankfurter Strasse 50



49 641797070

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was Jomaa Pharmaka founded?

    Jomaa Pharmaka was founded in 1998.

  • What is Jomaa Pharmaka's latest funding round?

    Jomaa Pharmaka's latest funding round is Series A.

  • How much did Jomaa Pharmaka raise?

    Jomaa Pharmaka raised a total of $6.24M.

  • Who are the investors of Jomaa Pharmaka?

    Investors of Jomaa Pharmaka include Fundamenta Capital, IMH Industrie Management and TBG.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.